Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018			109,491,277
Beginning balance at Dec. 31, 2018	$ 2,831		$ 11	$ 887,289	$ (884,122)	$ (347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	707			707
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)			430,370
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes	(53)			(53)
Assignment of NantHealth Labs (see Note 20)	20			20
Other comprehensive loss	55					55
Net income (loss)	(19,923)	[1]			(19,923)
Ending balance (in shares) at Mar. 31, 2019			109,921,647.000
Ending balance at Mar. 31, 2019	(16,363)		$ 11	887,963	(904,045)	(292)
Beginning balance (in shares) at Dec. 31, 2019			110,619,678
Beginning balance at Dec. 31, 2019	(57,136)		$ 11	889,955	(946,884)	(218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	668			668
Other comprehensive loss	(188)					(188)
Net income (loss)	23,065	[1]			23,065
Ending balance (in shares) at Mar. 31, 2020			110,619,678.000
Ending balance at Mar. 31, 2020	$ (33,591)		$ 11	$ 890,623	$ (923,819)	$ (406)

[1] The statements for the three months ended March 31, 2020 and 2019 include the Connected Care Business (see Note 4).